The recently discovered class 2 CRISPR-Cas endonuclease Cpf1 offers several advantages over Cas9, including the ability to process its own array and requirement for just a single RNA guide.
Given previous work showing that different Cas9 orthologs exhibit a range of activity in eukaryotic cells (Cong et al., 2013; Ran et al., 2015) and the potential advantages of Cpf1, we sought to identify additional Cpf1 orthologs with high activity in eukaryotic cells. Here we examine 16 new Cpf1-family proteins for nuclease activity in human cells. We identify four orthologs that can induce insertion/deletion (indel) events at targeted genomic loci. One ortholog, from Moraxella bovoculi AAX11_00205 (Mb3Cpf1), exhibited comparable activity to AsCpf1 and LbCpf1 when targeted sites containing TTTV (V = A, C, or G) PAMs. We also show that Mb3Cpf1 can recognize a TTN PAM, but with lower efficiency than the conserved TTTV PAM.
Together, these new orthologs expand the genome editing toolbox, providing new enzymes that can be used for tailored applications.
We selected 16 uncharacterized Cpf1-family proteins with varying degrees of homology to three Cpf1 orthologs with confirmed activity in eukaryotic cells (FnCpf1, AsCPf1, and LbCpf1) (Endo et al., 2016; Zetsche et al., 2015) ( Figure 1A ). The direct repeat (DR) sequences of crRNAs associated with Cpf1 orthologs show high levels of homology ( Figure 1B ) and are predicted to fold into almost identical secondary structures ( Figure 1C ). The homology is particularly strong at the stem structure and the AAUU motif ( Figure 1C ), which is required for efficient crRNA maturation (Fonfara et al., 2016) , suggesting the mechanism of crRNA maturation may be conserved within the Cpf1-family. We performed a previously described in vitro assay (Gao et al., 2016) to determine the sequence of the PAM for each Cpf1 ortholog (Figure 2A ). Of the 16 new Cpf1 proteins, 10 were active in vitro and recognized a T-rich PAM located 5' of the targeted sequence ( Figure 2B ), similar to previously characterized Cpf1 proteins .
Next we tested if any of the 16 Cpf1 orthologs are active in human cells. We chose a previously validated target within VEGFA, located next to a TTTG PAM, permissive to all Cpf1 orthologs.
HEK293T cells were transfected with plasmids encoding humanized Cpf1 orthologs together with PCR amplified fragments comprising a U6 promoter fused to the corresponding crRNA sequence ( Figure 3A) . Four of the new Cpf1 orthologs (Thiomicrospira sp. Xs5 (TsCpf1),
and Butyrivibrio sp. NC3005 (BsCpf1)) were able to induce detectable indel events, as measured by surveyor nuclease assay ( Figure 3B ). We tested these orthologs with six additional guides targeting either DNMT1 or EMX1 next to TTTV PAMs ( Figure 3C ) and compared them to the activity of AsCpf1 and LbCpf1. For all four Cpf1 enzymes, indel frequencies of >20% could be detected for at least two guides but only Mb3Cpf1 was able to induce robust indel levels with all six guides, comparable to AsCpf1 and LbCpf1. The apparent difference in activity between Mb2Cpf1 and Mb3Cpf1 was somewhat surprising given that these orthologs share a predicted homology of 94.7%.
Because Mb3Cpf1 was predicted to recognize a less restrictive PAM than the TTTV consensus PAM of AsCpf1 and LbCpf1 ( Figure 2B 
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and LbCpf1, which are only active at the canonical TTTV. Previously, we observed only weak activity of FnCpf1 in mammalian cells . However, a recent study found that FnCpf1 exhibits robust activity in plant cells (Endo et al., 2016) , indicating that Cpf1 orthologs might have different activity depending on the organism. The availability of another Cpf1 ortholog with high activity in eukaryotic cells will further expand the genome editing options for a wide range of organisms.
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Methods
Computational search for Cpf1 orthologs. Cpf1 orthologs were selected as previous described .
Cell culture and transfection. HEK293T cells were maintained at 37°C with 5% CO 2 in Dulbecco Modified Eagle Medium (Gibco) supplemented with 10% fetal bovine serum (HyClone) and 2 mM GlutaMAX (Life Technology). For indel analysis 22,000 cells were seeded per 96-well (Corning) one day before transfection. Each well was transfected with 100 ng Cpf1 encoding plasmid (see Table 1 ) and 50 ng guide encoding plasmid or PCR fragment, or 150 ng Cpf1 and guide encoding plasmid, using Lipofectamine 2000 (Thermo Fisher Scientific). Cell were harvested 3 days after transfection with QuickExtract DNA extraction solution according to the manufacturer's protocol and analyzed by surveyor assay or deep sequencing. For generation of Cpf1 containing whole cell lysate, 120,000 cells were seeded per 24-well (Corning) one day before transfection. Each well was transfected with 500 ng Cpf1 encoding plasmid and cell lysate was harvested 2 days after transfection.
In vitro PAM identification assay. The in vitro PAM identification assay was performed as described previously (Gao et al., 2016) . Briefly, whole cell lysate from HEK293T cells, overexpressing one of the Cpf1 orthologs was prepared with lysis buffer (20 mM HEPES, 100 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 5% glycerol, 0.1% Triton X-100) supplemented with EDTA-free cOmplete Protease Inhibitor Cocktail (Roche). CrRNA with corresponding direct repeat sequences were transcribed in vitro using custom oligonucleotides and HiScribe T7 in vitro Transcription Kit (NEB) according to the manufacturer's recommended protocol for small RNA transcripts. The PAM library consisted of a pUC19 plasmid carrying a degenerate 8-bp sequence 5' of a 33-bp target site . The library was pre-cleaved with XmnI and column purified prior to use (Qiagen). Each in vitro cleavage reaction consisted of 1 ul 10x CutSmart buffer (NEB), 200 ng PAM library, 500 ng in vitro transcribed crRNA, 10 ul cell lysate and water for a total volume of 20 ul. Reactions were incubated at 37°C for one hour and stopped by adding 500 ul buffer PB (Qiagen) followed by column purification. Purified DNA was amplified and sequenced using a MiSeq (Illumina) with a single-end 150-cycle kit. Sequencing results were entered into the PAM discovery pipeline .
Surveyor assay. Surveyor assay was performed as previous described (Hsu et al., 2013) . Briefly, genomic regions flanking a target side for each gene were amplified by PCR and products were purified by QiaQuick Spin Column (Qiagen). 400 ng total purified PCR products were mixed with 2 μl 10 Taq DNA Polymerase buffer (Enzymatics) and ultrapure water to a final volume of 20 μl, and re-annealed by heating to 95°C for 2 min and slow cool down to 10°C (~2.5°C per min). Re-annealed products were treated with surveyor nuclease (IDT) according to the manufacturer's protocol and cleavage products were visualized on 10% Novex TBE polyacrylamide gels (Life Technologies). Gels were stained with SYBR Gold DNA stain (Life Technologies) for 10 min and imaged with a Gel Doc imaging system (Bio-Rad).
Deep Sequencing. Targeted regions were amplified using a previously described two-step PCR protocol (Hsu et al., 2013) . Indels were counted computationally as previously described (Gao et al., 2016) . Briefly, each amplicon was searched for exact matches within a 70-bp window around the cut side. For each sample, the indel rate was determined as (number of reads with indel) / (number of total reads). Samples with fewer than 1000 total reads were not included in subsequent analyses. ATTA  ATTG  ATTC  ATTT  GTTA  GTTG  GTTC  GTTT  CTTA  CTTG  CTTC  CTTT  TTTA  TTTG  TTTC  TTTT  ATTA  ATTG  ATTC  ATTT  GTTA  GTTG  GTTC  GTTT  CTTA  CTTG  CTTC  CTTT  TTTA  TTTG  TTTC  TTTT  ATTA  ATTG  ATTC  ATTT  GTTA  GTTG  GTTC  GTTT  CTTA  CTTG  CTTC  CTTT  TTTA  TTTG  TTTC Figure 4
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